Inventor · disambiguated record
Richard J. Austin
Also filed as: AUSTIN RICHARD · AUSTIN RICHARD J · AUSTIN RICHARD J W · AUSTIN RICHARD M
24 granted patents·17 pending applications·241 citations·filing 2002–2024
96Inventor score
Top patents by PatentIndex Score
41 records- 0197US11180563B2FLT3 binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2021·Granted Nov 23, 2021·10 cites·27 claims
- 0296US10543271B2Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·13 cites·18 claims
- 0396US10100106B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·27 cites·26 claims
- 0496US9920115B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·31 cites·12 claims
- 0595US11085021B2Compositions and methods for TCR reprogramming using fusion proteinsTCR2 THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·3 cites·27 claims
- 0695US10849973B2Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Dec 1, 2020·10 cites·8 claims
- 0795US10844134B2PSMA targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Granted Nov 24, 2020·12 cites·11 claims
- 0895US10815311B2DLL3 binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·14 cites·16 claims
- 0995US10730954B2MSLN targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·14 cites·2 claims
- 1095US10066016B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Sep 4, 2018·34 cites·13 claims
- 1194US11136403B2Trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2018·Granted Oct 5, 2021·11 cites·13 claims
- 1294US10927180B2B cell maturation antigen binding proteinsHARPOON THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·8 cites·18 claims
- 1392US10544221B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Jan 28, 2020·14 cites·17 claims
- 1483US7371381B2Anti-galanin antibodies and uses thereofAMGEN INC·Filed 2004·Granted May 13, 2008·24 cites·25 claims
- 1582US8153633B2Phthalazine compounds, compositions and methods of useAUSTIN RICHARD J·Filed 2008·Granted Apr 10, 2012·7 cites·27 claims
- 1681US11623958B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Apr 11, 2023·1 cites·24 claims
- 1780US11453716B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·1 cites·20 claims
- 1879US2024327534A1B cell maturation antigen binding proteinsHARPOON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1978US2024141072A1Dll3 binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2076US2024100157A1Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2171US11976125B2B cell maturation antigen binding proteinsHARPOON THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 2271US2024084009A1Single chain variable fragment cd3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2370US12371504B2Trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2021·Granted Jul 29, 2025·0 cites·25 claims
- 2469US11607453B2Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Mar 21, 2023·0 cites·19 claims
- 2567US11807692B2DLL3 binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2020·Granted Nov 7, 2023·0 cites·20 claims
- 2664US2022098311A1Flt3 binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2762US2024084035A1Combination therapy with immune cell engaging proteins and immunomodulatorsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2861US2021100902A1Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2959US2021095047A1PSMA Targeting Trispecific Proteins and Methods of UseHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3059US2024336909A1Conditional activation of immunoglobulin moleculesHARPOON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3156US2024216518A1Extended-release immune cell engaging proteins and methods of treatmentHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3251US2020270362A1Msln targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3350US12195544B2EGFR binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2019·Granted Jan 14, 2025·0 cites·29 claims
- 3449US2024228656A1Epcam targeting trispecific protein for treatment of cancerHARPOON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3547US2022054544A1Conditionally active receptorsHARPOON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3643US12415860B2Binding moiety for conditional activation of immunoglobulin moleculesHARPOON THERAPEUTICS INC·Filed 2019·Granted Sep 16, 2025·0 cites·20 claims
- 3743US2021269530A1Conditionally activated binding protein comprising a sterically occluded target binding domainHARPOON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3843US2021284728A1Dual binding moietyHARPOON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3939US2007202056A1Oral composition for improving mouth environmentLOSEE PAUL·Filed 2006·Application pending·0 cites
- 4039US2003072829A1Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefromFiled 2002·Application pending·0 cites
- 4136USD581121SUmbrella-type clothes drying line with removable coverAUSTIN CARMEL·Filed 2005·Granted Nov 18, 2008·7 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Richard J. Austin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →